316 related articles for article (PubMed ID: 31832759)
1. The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis.
Schwarzer R; Reiberger T; Mandorfer M; Kivaranovic D; Hametner S; Hametner S; Paternostro R; Scheiner B; Schneeweiss-Friedl J; Trauner M; Schoefl R; Maieron A
J Gastroenterol; 2020 May; 55(5):533-542. PubMed ID: 31832759
[TBL] [Abstract][Full Text] [Related]
2. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
[TBL] [Abstract][Full Text] [Related]
3. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
4. Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased Mortality.
Hundersmarck D; Groot OQ; Schuijt HJ; Hietbrink F; Leenen LPH; Heng M
Clin Orthop Relat Res; 2022 Jun; 480(6):1077-1088. PubMed ID: 34978539
[TBL] [Abstract][Full Text] [Related]
5. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.
Balcar L; Tonon M; Semmler G; Calvino V; Hartl L; Incicco S; Jachs M; Bauer D; Hofer BS; Gambino CG; Accetta A; Brocca A; Trauner M; Mandorfer M; Piano S; Reiberger T;
JHEP Rep; 2022 Aug; 4(8):100513. PubMed ID: 35845294
[TBL] [Abstract][Full Text] [Related]
6. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
[TBL] [Abstract][Full Text] [Related]
7. Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis.
Navadurong H; Thanapirom K; Wejnaruemarn S; Prasoppokakorn T; Chaiteerakij R; Komolmit P; Treeprasertsuk S
World J Gastroenterol; 2023 Aug; 29(32):4873-4882. PubMed ID: 37701131
[TBL] [Abstract][Full Text] [Related]
8. Liver-to-Spleen Volume Ratio Automatically Measured on CT Predicts Decompensation in Patients with B Viral Compensated Cirrhosis.
Kwon JH; Lee SS; Yoon JS; Suk HI; Sung YS; Kim HS; Lee CM; Kim KM; Lee SJ; Kim SY
Korean J Radiol; 2021 Dec; 22(12):1985-1995. PubMed ID: 34564961
[TBL] [Abstract][Full Text] [Related]
9. Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.
Liu TL; Trogdon J; Weinberger M; Fried B; Barritt AS
Dig Dis Sci; 2016 Nov; 61(11):3335-3345. PubMed ID: 27480088
[TBL] [Abstract][Full Text] [Related]
10. Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient ≥20 mm Hg.
Jindal A; Bhardwaj A; Kumar G; Sarin SK
Am J Gastroenterol; 2020 Oct; 115(10):1624-1633. PubMed ID: 32453061
[TBL] [Abstract][Full Text] [Related]
11. Role of the von Willebrand factor and the VITRO score as predictors for variceal bleeding in patients with hepatitis C-related cirrhosis.
Ibrahim EH; Marzouk SA; Zeid AE; Lashen SA; Taher TM
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):241-247. PubMed ID: 30281535
[TBL] [Abstract][Full Text] [Related]
12. Natural history of compensated viral B and D cirrhosis.
Gheorghe L; Iacob S; Simionov I; Vadan R; Gheorghe C; Iacob R; Parvulescu I; Constantinescu I
Rom J Gastroenterol; 2005 Dec; 14(4):329-35. PubMed ID: 16400347
[TBL] [Abstract][Full Text] [Related]
13. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia.
Kalambokis GN; Oikonomou A; Christou L; Kolaitis NI; Tsianos EV; Christodoulou D; Baltayiannis G
J Hepatol; 2016 Nov; 65(5):921-928. PubMed ID: 27297911
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
Rincón D; Lo Iacono O; Tejedor M; Hernando A; Ripoll C; Catalina MV; Salcedo M; Matilla A; Senosiain M; Clemente G; Molinero LM; Albillos A; Bañares R
Scand J Gastroenterol; 2013 Apr; 48(4):487-95. PubMed ID: 22871085
[TBL] [Abstract][Full Text] [Related]
15. Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis.
Orman ES; Roberts A; Ghabril M; Nephew L; Desai AP; Patidar K; Chalasani N
JAMA Netw Open; 2019 Jun; 2(6):e196412. PubMed ID: 31251379
[TBL] [Abstract][Full Text] [Related]
16. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
Villanueva C; Albillos A; Genescà J; Garcia-Pagan JC; Calleja JL; Aracil C; Bañares R; Morillas RM; Poca M; Peñas B; Augustin S; Abraldes JG; Alvarado E; Torres F; Bosch J
Lancet; 2019 Apr; 393(10181):1597-1608. PubMed ID: 30910320
[TBL] [Abstract][Full Text] [Related]
17. Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis.
Villanueva C; Albillos A; Genescà J; Garcia-Pagan JC; Brujats A; Calleja JL; Aracil C; Bañares R; Morillas RM; Poca M; Peñas B; Augustin S; Abraldes JG; Alvarado E; Torres F; Bosch J;
J Hepatol; 2021 Sep; 75(3):589-599. PubMed ID: 33905794
[TBL] [Abstract][Full Text] [Related]
18. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC
Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197
[TBL] [Abstract][Full Text] [Related]
19. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
[TBL] [Abstract][Full Text] [Related]
20. Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.
Frenette C; Kayali Z; Mena E; Mantry PS; Lucas KJ; Neff G; Rodriguez M; Thuluvath PJ; Weinberg E; Bhandari BR; Robinson J; Wedick N; Chan JL; Hagerty DT; Kowdley KV;
J Hepatol; 2021 Feb; 74(2):274-282. PubMed ID: 33038432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
